•  Nasdaq

  •  OTC BB


    GlaxoSmithKline (GSK) Gets FDA Approval for Raxibacumab Anti-Toxin for the Treatment of Inhalational Anthrax

    December 15 Dec 2012 | 11:05




    http://pennyomega.com/img/gsk.jpg GSK, GlaxoSmithKline plc


    ** GSK reported that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

    The effectiveness of raxibacumab is based solely on efficacy studies in animal models as it is not ethical or feasible to conduct controlled clinical trials with intentional exposure of humans to anthrax.

    The safety of raxibacumab has been studied in healthy adult volunteers, however, there have been no studies of raxibacumab in the pediatric population.

    Raxibacumab is the first monoclonal anti-toxin to be approved for inhalational anthrax. Anthrax is a rare and lethal disease, caused by a toxin producing bacterium.

    While antibiotics target the anthrax bacteria, raxibacumab offers an additional mechanism by blocking the activity of the anthrax toxin, which plays a key role in the progression of the disease.


    GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

    More about GSK at www.gsk.com


    Read Full Disclaimer at http://CRWENews.com/disclaimer

    Tags: , ,



      Exclusive Video
  • EQCO2, Inc. Fraud Lawsuit

  • Hot stocks to watch!

    JA Solar Holdings Co Ltd - JASO

    Mattel, Inc - MAT

    Starbucks Corp - SBUX

    Crown Equity Holdings Inc. - CRWE

    Financial Select Sector SPDR ETF - XLF

    Baidu Inc - BIDU


    Freeport-McMoRan Copper & Gold - FCX

    Sprint Nextel Corp - S


    Pfizer Inc - PFE

    PowerShares QQQ - QQQQ

    Bank of America Corporation - BAC

    RF Micro Devices - RFMD

    Directv - DTV

    Flextronics International Ltd - FLEX

    Merck & Co Inc new - MRK

    Applied Materials Inc - AMAT

    Petroleo Brasileiro SA - PBR

    Weatherford Internation Lt - WFT

    Kingdom Koncrete Inc. - KGKO

    iShares MSCI Emerging Markets Index ETF - EEM

     CRWE Network